Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
| ▸ | ACACB | O00763 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ACACA | Q13085 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1312293 | 0.85 | FAAH (0.56) | ACACB | |
| SCHEMBL1312295 | 0.85 | FAAH (0.56) | ACACB | |
| SCHEMBL19700902 | 0.81 | HTT (0.49) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL20270868 | 0.81 | HTT (0.49) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL21399933 | 0.77 | CNR1 (0.48) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL21399858 | 0.76 | CNR1 (0.49) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL19700718 | 0.75 | CNR1 (0.44) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL21378381 | 0.75 | CNR1 (0.44) | HTTCNR1ACACBALDH1A1KMT2A | |
| SCHEMBL12122235 | 0.75 | CA12 (0.47) | HTTEPHX2CNR1ALDH1A1KMT2A | |
| SCHEMBL22572280 | 0.74 | CNR1 (0.44) | HTTCNR1ACACBALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3464281-A1 | MUTANT IDH1 INHIBITORS | Eli Lilly and Company (US) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017213910-A1 | MUTANT IDH1 INHIBITORS | ELI LILLY AND COMPANY (US) | 2017-12-14 | — | — | WO | disclosed |